Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0JO8Z
|
||||
| Former ID |
DNAP001648
|
||||
| Drug Name |
Fosfestrol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Approved | [551871] | ||
| Formula |
C18H22O8P2
|
||||
| Canonical SMILES |
CCC(=C(CC)C1=CC=C(C=C1)OP(=O)(O)O)C2=CC=C(C=C2)OP(=O)(O<br />)O
|
||||
| InChI |
1S/C18H22O8P2/c1-3-17(13-5-9-15(10-6-13)25-27(19,20)21)18(4-2)14-7-11-16(12-8-14)26-28(22,23)24/h5-12H,3-4H2,1-2H3,(H2,19,20,21)(H2,22,23,24)/b18-17+
|
||||
| InChIKey |
NLORYLAYLIXTID-ISLYRVAYSA-N
|
||||
| CAS Number |
CAS 13425-53-1
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
10345, 7848009, 7979318, 10047183, 15329796, 36076580, 50047749, 50125929, 57352633, 76531220, 103770581, 111631913, 115354413, 126603657, 131549784, 134931955, 134977604, 137156414, 137545234, 143449629, 144206347, 162059604, 162172997, 163693541, 172858626, 179226216, 179316276, 184546059, 198986325, 223439533, 223535890, 225040070, 226400299, 241090562, 252350068
|
||||
| SuperDrug ATC ID |
G03CB02; G03CC05; L02AA04
|
||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Modulator | [527592], [530110] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.